Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Vertex CEO pay package tops $28 million

By , Globe Staff

Jeffrey Leiden’s 2015 earnings were 23 percent less than he received the previous year.

Vertex sees blockbuster status for cystic fibrosis treatment in first year

By , Globe Staff

Despite the prediction, the company’s estimate that Orkambi’s revenues will be up to $1.1 billion this year falls short of projections.

Biogen taps Pfizer exec as new research chief

By , Globe Staff

The Cambridge biotech said that Michael Ehlers will oversee global drug discovery, clinical development, and medical affairs.

Sarepta’s stock is plummeting

By , Globe Staff

Shares of the Cambridge biotech were trading down the day after an FDA panel voted against recommending approval of its experimental drug.